Evidence map›Paper›PMID 39246687›Full record

ArticleClinical pathology (Thousand Oaks, Ventura County, Calif.)

Primary Breast Lymphoma: A Case Report of a Common Tumor in an Uncommon Location.

Alex Mremi, Hilary Chipongo, Ellyagape Urassa, Elifuraha Mkwizu, Jay Lodhia

Abstract readCase Reports
In one paragraph

Article in Clinical pathology (Thousand Oaks, Ventura County, Calif.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alex MremiDepartment of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.ORCID https://orcid.org/0000-0001-7226-0168
Hilary ChipongoDepartment of General Surgery, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Ellyagape UrassaDepartment of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Elifuraha MkwizuFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Jay LodhiaFaculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary breast lymphoma (PBL) is a rare malignant lymphoid neoplasm limited to the breast, accounting for about 0.15% of all malignant breast tumors and 1.7% to 2.2% of extra-nodal lymphomas. PBL must be distinguished from conventional breast carcinomas due to different therapeutic approaches. A 25-year-old female presented with a left breast mass. Histopathology and immunohistochemical tests confirmed the diagnosis of diffuse large B-cell lymphoma (DLBCL). She had no similar lesions elsewhere in the body. She received 1 cycle of R-CHOP chemotherapy but absconded from the treatment and succumbed afterward while at home. Recent developments in DLBCL treatment have greatly improved patient outcomes by incorporating targeted medicines like rituximab, increased chemotherapy regimens, new drugs, and individualized treatment techniques. PBL appears to have a worse prognosis; thus, delay or abscondment from treatment is of serious concern when it comes to improving the prognosis of patients with PBL.

Indexed as

Breastcase reportdiagnosisdiffuse large B-cell lymphomaprimaryprognosis

Identifiers

PMID39246687
PMCPMC11380124

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.